A leading rare disease therapeutics company partnered with Valeris to manage its patient support program for people living with serious kidney conditions. The program served hundreds of patients each month, but one obstacle keep interfering: a slow, paper-heavy prior authorization process that left patients waiting - and sometimes walking away - before treatment began.

Within months of launching Valeris's new electronic prior authorization (ePA) platform, that story changed dramatically.

Together, Valeris and its client proved that with the right technology, and a team determined to make it work, patients can start life-saving therapy faster.